v3 Template
P

Portage Biotech, Inc.

Biotechnology / Immuno-Oncology DOVER, Del. ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$10.9M
Funding Rounds
3
Last Funding
2025-01-30

About Portage Biotech, Inc.

Portage Biotech is a clinical-stage immuno-oncology company focused on advancing first-in-class therapies that target known checkpoint resistance pathways to achieve durable treatment responses and improve the quality of life for cancer patients. They aim to revolutionize cancer research and development through diverse drug platforms, strategic counsel, and a strong industry network, with a portfolio of five platforms and ten novel assets in preclinical or clinical development.

Products & Services

iNKT Platform:A platform focused on iNKT agonists for cancer treatment.
Adenosine Platform:A portfolio targeting adenosine pathways for cancer therapies.
Other Programs in Development:Additional novel programs under development for cancer resistance pathways.

Specialties

Immuno-Oncology Cancer Research and Development Checkpoint Resistance Pathways Drug Platform Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement
A: 2150000
MR: -
FA: $2.15 million
FAN: 2150000
D: 2025-01-30
FD: 2025-01-30
1 investors
2 RT: Non-dilutive
T: -
FT: Non-dilutive
A: 2800000
MR: -
FA: $2.8M
FAN: 2800000
D: 2024-03-26
FD: 2024-03-26
-
3 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 6000000
MR: -
FA: $6.0 million
FAN: 6000000
D: 2023-09-29
FD: 2023-09-29
1 investors
Private Placement Latest
2025-01-30
$2.1M
1 investor (Pro only)
Non-dilutive 2024-03-26
$2.8M
Registered Direct Offering 2023-09-29
$6.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Robert Kramer

Chief Scientific Officer

A

Andrea Park

Chief Financial Officer

A

Adam Melero

Controller

A

Alexander Pickett

CEO and Director

G

Gregory Bailey

Lead Director

S

Steven Mintz

Director

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Portage Biotech, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Immuno-Oncology
Company Size
~135 employees (est.)
Locations
DOVER, Del.
Dover, Del.
Dover, Delaware

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro